Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 122 (CCDC122) is a human protein encoded by the CCDC122 gene. It contains a coiled-coil domain, but its molecular function and biological roles are currently poorly defined. Naturally occurring mutations in CCDC122 have been associated with susceptibility to leprosy, and deletions in the gene have been implicated in cancer progression such as in prostate cancer[6][7]. Beyond these associations, the protein does not belong to standard therapeutic target classes like receptor, enzyme, ion channel, or transporter, and no approved drugs or characterized mechanisms of action targeting CCDC122 are reported[6][10]. The protein is listed in clinical and bioinformatics databases, highlighting its role as a protein-coding gene, but no disease-specific therapies, biomarker roles, or safety concerns have been established based on current evidence[6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 122 (CCDC122).